NLBS: AI 评分 38/100 — AI 分析 (4月 2026)

NutraLife BioSciences, Inc. develops, manufactures, and distributes nutraceutical, dietary, wellness, and cannabidiol (CBD) products. The company offers a range of CBD and non-CBD products through its website, private label distributors, online retailers, and retail outlets.

Key Facts: AI Score: 38/100 Sector: Healthcare

公司概况

概要：

NutraLife BioSciences, Inc. focuses on the development, manufacture, and distribution of nutraceutical, dietary, wellness, and CBD products. Operating in the specialty and generic drug manufacturing sector, the company offers a diverse product line, including CBD-infused and traditional wellness items, sold through multiple channels, including online and retail partnerships.

NLBS是做什么的？

NutraLife BioSciences, Inc., established in 2010 and based in Coconut Creek, Florida, operates in the nutraceutical, dietary, wellness, and CBD product space. Originally incorporated as NutraFuels, Inc., the company rebranded in March 2019 to NutraLife BioSciences, Inc., signaling a strategic shift towards a broader wellness portfolio. The company develops, manufactures, and distributes a variety of products, including cannabinoid-rich hemp oil derived from industrial hemp, tinctures, topical lotions and oils, face creams, massage oils, nutraceutical sprays with CBD, and pet products. Additionally, NutraLife BioSciences offers skincare and sanitizer products, catering to a diverse consumer base seeking wellness and health solutions. NutraLife BioSciences sells its products through its online platform, nutralifebiosciences.com, and leverages partnerships with private label distributors, online retailers, and traditional retail outlets to expand its market reach. The company's focus on both CBD and non-CBD wellness products positions it within the evolving landscape of consumer health and alternative medicine.

NLBS的投资论点是什么？

NutraLife BioSciences, Inc. presents a speculative investment opportunity within the nutraceutical and CBD market. The company's small size and OTC listing introduce significant risk, highlighted by a negative profit margin of -930.0% and a volatile beta of -15.21. Growth hinges on successful expansion of its product lines and distribution networks, particularly in the competitive CBD market. Investors should closely monitor revenue growth, cost management, and regulatory developments affecting the CBD industry. The company's ability to achieve profitability and navigate the OTC market's challenges will be critical for long-term viability. The absence of a dividend further emphasizes the speculative nature of this investment.

NLBS在哪个行业运营？

NutraLife BioSciences operates within the specialty and generic drug manufacturing industry, a segment experiencing growth driven by increasing consumer interest in wellness and alternative medicine. The market for CBD products is expanding but faces regulatory uncertainty and intense competition. Companies like ACCA, ACORQ, CBDHF, CHCR, and DGCRF represent key competitors. Success in this landscape requires effective branding, product differentiation, and navigating the evolving regulatory environment surrounding CBD and nutraceutical products.

Drug Manufacturers - Specialty & Generic

Healthcare

NLBS有哪些增长机遇？

Expansion of CBD Product Lines: The growing market for CBD products presents a significant opportunity for NutraLife BioSciences. By introducing new CBD-infused products, such as edibles, beverages, and specialized formulations, the company can attract a wider customer base. The global CBD market is projected to reach billions of dollars in the coming years, offering substantial revenue potential if NutraLife can effectively innovate and market its offerings. Timeline: Ongoing.
Strategic Partnerships with Retailers: Collaborating with major retail chains and online marketplaces can significantly expand NutraLife BioSciences' distribution network. Securing shelf space in established stores and online platforms provides access to a larger audience and enhances brand visibility. This strategy can drive sales volume and establish a stronger market presence. The timeline for securing such partnerships typically ranges from several months to a year. Market size: National and international retail market.
Development of Private Label Products: Offering private label manufacturing services to other companies can generate a stable revenue stream for NutraLife BioSciences. By leveraging its manufacturing capabilities, the company can produce custom formulations and branded products for other businesses, capitalizing on the growing demand for private label wellness products. Timeline: Within the next 1-2 years.
Geographic Expansion into New Markets: Expanding into new geographic markets, both domestically and internationally, can unlock significant growth opportunities. By targeting regions with high consumer demand for wellness products and favorable regulatory environments, NutraLife BioSciences can diversify its revenue streams and reduce reliance on its existing markets. Market size: Global wellness and nutraceutical market. Timeline: 2-3 years.
Investment in Online Marketing and E-commerce: Enhancing its online presence through targeted marketing campaigns and improvements to its e-commerce platform can drive direct-to-consumer sales. By optimizing its website for search engines, utilizing social media marketing, and implementing email marketing strategies, NutraLife BioSciences can attract new customers and increase online revenue. Market size: Global e-commerce market. Timeline: Ongoing.

NutraLife BioSciences operates with a small team of 12 employees, indicating a lean operational structure.
The company's gross margin stands at 13.3%, reflecting the profitability of its product sales after accounting for the cost of goods sold.
The company's profit margin is -930.0%, indicating significant losses relative to its revenue.
NutraLife BioSciences has a beta of -15.21, suggesting an inverse correlation to the market and high volatility.
The company does not offer a dividend, indicating that it is reinvesting earnings back into the business.

NLBS提供哪些产品和服务？

Develops nutraceutical products.
Manufactures dietary supplements.
Creates wellness products.
Produces cannabidiol (CBD) products.
Offers cannabinoid-rich hemp oil.
Distributes products through online and retail channels.

NLBS如何赚钱？

Develops and manufactures nutraceutical, dietary, wellness, and CBD products.
Sells products directly to consumers through its website.
Partners with private label distributors.
Distributes products through online retailers and retail outlets.

Individual consumers seeking nutraceutical and wellness products.
Private label distributors looking for product manufacturing.
Online retailers selling health and wellness products.
Retail outlets offering dietary supplements and CBD products.

Proprietary formulations for nutraceutical and CBD products.
Established manufacturing capabilities.
Distribution network through online and retail channels.
Brand recognition in the wellness market.

什么因素可能推动NLBS股价上涨？

Upcoming: Potential regulatory changes in the CBD market could create new opportunities or challenges.
Ongoing: Expansion of product lines and entry into new markets.
Ongoing: Strategic partnerships with retailers and distributors.
Upcoming: Release of new clinical studies supporting the efficacy of its products.
Ongoing: Increased consumer awareness and demand for wellness products.

NLBS的主要风险是什么？

Potential: Intense competition in the CBD and nutraceutical markets.
Potential: Changing regulatory landscape for CBD products.
Ongoing: Negative profit margin indicates financial instability.
Potential: Product liability claims.
Ongoing: Dependence on evolving consumer preferences.

NLBS的核心优势是什么？

Diverse product line including nutraceutical, dietary, wellness, and CBD products.
Multiple distribution channels including online, retail, and private label.
Established manufacturing capabilities.
Focus on emerging wellness market trends.

NLBS的劣势是什么？

Negative profit margin indicates financial instability.
Small company size with limited resources.
OTC listing implies higher risk and lower liquidity.
Dependence on evolving regulatory environment for CBD products.

NLBS有哪些机遇？

Expansion into new geographic markets.
Development of innovative CBD-infused products.
Strategic partnerships with major retailers.
Growth in the overall wellness and nutraceutical market.

NLBS面临哪些威胁？

Intense competition in the CBD and nutraceutical markets.
Changing regulatory landscape for CBD products.
Potential for product liability claims.
Economic downturn impacting consumer spending on wellness products.

NLBS的竞争对手是谁？

Accera, Inc. — Focuses on neurodegenerative disease treatments. — (ACCA)
Acorda Therapeutics, Inc. — Develops therapies for neurological disorders. — (ACORQ)
CBD of Denver, Inc. — CBD product manufacturer and distributor. — (CBDHF)
China Commercial Credit, Inc. — Financial services company. — (CHCR)
Digicrypts Blockchain Solutions Inc. — Blockchain technology solutions provider. — (DGCRF)

Key Metrics

MoonshotScore: 38/100

Company Profile

CEO: Edgar Ward
Headquarters: Coconut Creek, US
Employees: 12
Founded: 2014

AI Insight

AI analysis pending for NLBS

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does NutraLife BioSciences, Inc. do?

NutraLife BioSciences, Inc. is involved in the development, manufacture, and distribution of a range of health and wellness products. These include nutraceuticals, dietary supplements, and cannabidiol (CBD) products. The company's business model focuses on creating and selling these products through its own website, as well as through partnerships with private label distributors, online retailers, and traditional retail outlets, targeting consumers interested in health and wellness solutions.

What do analysts say about NLBS stock?

As of 2026-03-16, there is no available analyst coverage for NutraLife BioSciences, Inc. due to its OTC listing and small market capitalization. Key valuation metrics such as price-to-earnings ratio are not meaningful due to the company's negative profitability. Investors should conduct their own thorough research and consider the risks associated with investing in OTC stocks before making any investment decisions. The company's growth potential is tied to its ability to expand its product lines and distribution networks.

What are the main risks for NLBS?

NutraLife BioSciences faces several key risks, including intense competition in the crowded CBD and nutraceutical markets, which could pressure pricing and market share. The evolving regulatory landscape for CBD products poses a significant uncertainty, as changes in regulations could impact the legality and marketability of its products. The company's negative profit margin indicates financial instability, raising concerns about its ability to fund future growth and operations. Additionally, product liability claims and dependence on consumer preferences in the rapidly changing wellness market represent ongoing challenges.